Supernus Pharmaceuticals Inc (SUPN)
Operating Expenses
$844.11M
TTM · Period ending: · USD
SUPN Operating Expenses
Latest reported$844.11Mperiod ending
Latest reported$844.11Mperiod ending
SUPN TTM Operating Expenses ($38.56M → $844.11M)
TTM operating expenses
High-resolution chart · PNG
SUPN operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 844,110,000 | |
| 737,243,000 | |
| 688,914,000 | |
| 640,827,000 | |
| 524,719,000 | |
| 516,074,000 | |
| 502,245,000 | |
| 521,272,000 | |
| 530,152,000 | |
| 534,371,000 | |
| 529,011,000 | |
| 493,368,000 | |
| 520,225,000 | |
| 526,414,000 | |
| 533,893,000 | |
| 559,811,000 | |
| 504,588,000 | |
| 448,528,000 | |
| 418,685,000 | |
| 364,753,000 | |
| 344,585,000 | |
| 335,192,000 | |
| 294,240,000 | |
| 267,731,000 | |
| 247,716,000 | |
| 232,974,000 | |
| 227,524,000 | |
| 243,898,000 | |
| 247,620,000 | |
| 249,702,000 | |
| 249,097,000 | |
| 227,143,000 | |
| 219,634,000 | |
| 205,400,000 | |
| 187,482,000 | |
| 179,852,000 | |
| 159,590,000 | |
| 150,919,000 | |
| 148,802,000 | |
| 139,507,000 | |
| 137,993,000 | |
| 130,977,000 | |
| 118,340,000 | |
| 109,118,000 | |
| 99,089,000 | |
| 93,133,000 | |
| 92,057,000 | |
| 88,892,000 | |
| 85,291,000 | |
| 76,789,000 | |
| 72,835,000 | |
| 66,044,000 | |
| 60,026,000 | |
| 53,618,000 | |
| 43,649,000 | |
| 40,100,000 | |
| 37,645,000 | |
| 37,443,000 | |
| 38,555,000 | |
| 39,030,530 | |
| 37,706,873 |